Company Overview

Company name: Viridium Pacific Group (TSX: VIR)
Also known as: Viridium Pacific
Description: Developer of cannabis and health care products. The company’s services include manufacturing natural health care, medicines, nutraceutical, bioceutical, cosmetic and cannabis products across, enabling its customers to get a range of consumer wellness and biotech products.
Year founded: 2013
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 12.74
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: TSX
Ticker: VIR
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million) -4.84
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): -4.83
Fiscal period: TTM 3Q2018
Financing Status: The company (TSX:VIR) is in talks to receive CAD 16 million of development capital from undisclosed investors through a private placement as of October 14, 2018. The net proceeds of the private placement will be used for the construction of the proposed 87,120 square feet growing facility, general working capital and closing costs.
Number of active investors:
Profile last updated: 15-Oct-2018
Last known valuation: 5.67
Last known valuation date: 24-Oct-2016